Results
115
Gain exposure to companies in the healthcare sector with a strong future outlook and robust financials.
115 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
BSX | US$75.00 | 0% | 49.3% | US$122.7b | US$78.52 | PE67.1x | E20.9% | n/a | ||
BSX | US$73.50 | -1.3% | 46.8% | US$122.7b | US$76.95 | PE67.1x | E20.9% | n/a | ||
QS50 | CHF 13.10 | 0.8% | 14.9% | CHF 22.1b | CHF 12.89 | PE76.9x | E21.7% | 0.6% | ||
CP60 | US$97.70 | -1.4% | 29.8% | US$21.9b | US$101.02 | PE60.8x | E23.0% | 0% | ||
TBH | US$216.00 | 0% | 16.8% | US$11.6b | US$226.34 | PE43.9x | E21.3% | 0.6% | ||
GM0N | US$63.00 | 0% | 32.9% | US$9.6b | US$70.76 | PE235.1x | E53.3% | n/a | ||
1CB | US$28.20 | 1.4% | 55.8% | US$9.0b | US$28.01 | PS2.6x | E70.4% | n/a | ||
6HL | US$18.70 | -2.1% | 0% | US$8.3b | US$29.88 | PE82.6x | E29.6% | n/a | ||
0P8 | US$170.55 | -1.8% | -25.2% | US$7.4b | US$177.54 | PE522.7x | E44.3% | n/a | ||
3M4 | US$119.20 | 8.7% | 44.7% | US$7.1b | US$136.04 | PE89.7x | E25.1% | n/a | ||
2HE | US$70.00 | 0% | 0% | US$7.0b | US$91.71 | PE66.1x | E33.6% | n/a | ||
2CV | UK£2.76 | 4.5% | 9.5% | UK£4.7b | UK£3.39 | PE41.1x | E21.0% | 2.0% | ||
2CVU | UK£10.80 | 0.9% | 9.6% | UK£4.7b | UK£13.25 | PE41.1x | E21.0% | 2.0% | ||
2DR | US$179.95 | -3.4% | -4.3% | US$6.0b | US$197.55 | PE1004.5x | E44.9% | n/a | ||
6HL0 | US$12.60 | 0.8% | -10.6% | US$6.0b | US$13.09 | PS2.5x | E57.7% | n/a | ||
7RA | US$67.50 | -2.2% | 1.5% | US$5.9b | US$94.67 | PS1.9x | E42.5% | n/a | ||
61L1 | SEK 24.50 | 4.5% | 121.5% | SEK 53.6b | SEK 15.64 | PE119.8x | E21.2% | 0.4% | ||
547 | DKK 17.40 | -1.1% | 87.1% | DKK 34.6b | DKK 16.80 | PE76.9x | E22.9% | 0% | ||
547A | DKK 17.26 | -2.3% | 74.2% | DKK 34.6b | DKK 16.67 | PE76.9x | E22.9% | 0% | ||
PQIA | US$62.50 | 0.8% | 131.5% | US$5.1b | US$67.01 | PE516.9x | E61.0% | n/a | ||
WGB | US$113.00 | -1.7% | 51.7% | US$4.2b | US$116.48 | PE40.1x | E21.1% | n/a | ||
1SP | US$28.40 | -2.7% | 2.9% | US$4.0b | US$34.94 | PS1.4x | E60.9% | n/a | ||
82W | US$15.98 | 13.0% | 168.9% | US$3.8b | US$19.71 | PE212.5x | E40.7% | n/a | ||
0I3 | US$58.50 | -4.9% | 10.4% | US$3.6b | US$60.23 | PS8.7x | E50.4% | n/a |